2016 annual financial data
Iovance Biotherapeutics 2016 Operating margin
Iovance Biotherapeutics 2016 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -53,639,000 USD and net income was -52,894,000 USD.
Operating cash flow was -32,668,000 USD.
Get free Iovance Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -53,639,000 USD
- Net income
- -52,894,000 USD
- Operating cash flow
- -32,668,000 USD